Medication info
J-Gaba CR Sustained Release Tablet 300 mg (Pregabalin)

J-Gaba CR Sustained Release Tablet 300 mg (Pregabalin)

Prescription medicationTablet
Ingredient · strength
Pregabalin›188.5mg / 1 tablet
Manufacturer / importer
Jeil Pharmaceutical Co., Ltd.
Appearance
White to pale yellow, rectangular, film-coated extended-release tablet
Packaging
30 tablets (6 tablets/PTP x 5)
Approval status
Active

MFDS item code 201900140 · Approved 2019.01.11 · Insurance code 649701830

Summary

Main use
Treatment of peripheral neuropathic pain in adults
Who uses it
Adults · Children
Adult dosage
This medicine should be administered once daily after the evening meal. It should be swallowed whole and should not be split, crushed, or chewed. A starting dose of 150 mg per day may be administered. Based on each patient's response and tolerability, the dose may be increased at weekly intervals to a maximum of 600 mg per day. Based on current clinical experience, if treatment with this medicine is discontinued, it should be tapered gradually, with intervals of at least 1 week. The safety and efficacy of this medicine have not been established in patients with renal impairment. The safety and efficacy of this medicine have not been established in patients with hepatic impairment. The safety and efficacy of this medicine have not been established in older adults aged 65 years or older.
Children's dosage
The safety and efficacy of this medicine have not been established in pediatric and adolescent patients under 19 years of age.

Ingredients

Manufacturer
Jeil Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of peripheral neuropathic pain in adults

  • Peripheral neuropathic pain
View approved original text

This medication is used for the relief of peripheral neuropathic pain in adults. It helps to reduce pain caused by nerve damage, thus assisting in the patient's daily life. It effectively controls pain and improves quality of life.

Dosage and Administration

Adult dosage

This medicine should be administered once daily after the evening meal. It should be swallowed whole and should not be split, crushed, or chewed. A starting dose of 150 mg per day may be administered. Based on each patient's response and tolerability, the dose may be increased at weekly intervals to a maximum of 600 mg per day. Based on current clinical experience, if treatment with this medicine is discontinued, it should be tapered gradually, with intervals of at least 1 week. The safety and efficacy of this medicine have not been established in patients with renal impairment. The safety and efficacy of this medicine have not been established in patients with hepatic impairment. The safety and efficacy of this medicine have not been established in older adults aged 65 years or older.

Children's dosage

The safety and efficacy of this medicine have not been established in pediatric and adolescent patients under 19 years of age.

Precautions

This medication may increase the risk of suicidal thoughts or behavior; therefore, if depression or mood changes occur during treatment, notify your doctor immediately. Do not use this medication if you are allergic to pregabalin or any of its ingredients. In diabetic patients, if weight gain occurs after this medication, it may be necessary to adjust the dosage of blood sugar control medications. If symptoms of angioedema appear, such as swelling of the face, mouth, or throat, stop taking the medication immediately and consult a doctor. Elderly patients may experience symptoms such as dizziness, drowsiness, or confusion, so caution should be exercised when starting treatment. This medication may cause blurred vision or other changes in vision; if these symptoms occur, consult a physician. Abruptly stopping this medication may lead to withdrawal symptoms such as insomnia, headache, anxiety, and nausea, so it should be gradually reduced under medical advice. If there is a history of substance abuse or mental illness, watch carefully for the risk of abuse when using this medication. Patients with impaired kidney function may need dosage adjustment. It should be administered with caution in patients with severe heart disease, as symptoms of heart failure may develop. Caution should be taken as co-administration with opioid analgesics increases the risk of central nervous system depression. Patients with compromised respiratory function or the elderly may be at higher risk for severe respiratory depression, necessitating dosage adjustments. During early pregnancy, there may be a risk of fetal malformation, so unless there is a specific reason, it should not be used during pregnancy, and women of childbearing age should use effective contraceptive methods. Breastfeeding females should consider discontinuing breastfeeding or the medication, as this drug may be passed into breast milk and affect the infant. Activities requiring attention, such as driving or operating machinery, should be avoided until drowsiness or dizziness resolves after taking this medication. In case of overdose, symptoms such as confusion, drowsiness, seizures may occur, and treatments like hemodialysis may be necessary if required. This medication should be kept out of the reach of children and should not be transferred to other containers. If symptoms such as skin rash, severe allergic reactions, or difficulty breathing occur while taking this medication, discontinue use and consult medical personnel immediately.

Side effects

  • Suicidal thoughts
  • suicidal behavior
  • depression
  • abnormal changes in mood and behavior
  • angioedema
  • facial swelling
  • perioral edema
  • upper respiratory tract edema
  • dizziness
  • drowsiness
Show 146 more
  • loss of consciousness
  • confusion
  • mental disorder
  • blurred vision
  • vision changes
  • insomnia
  • headache
  • nausea
  • diarrhea
  • influenza-like illness
  • restlessness
  • suicidal thoughts
  • pain
  • seizures
  • sweating
  • weight gain
  • constipation
  • dyspepsia
  • nausea
  • dry mouth
  • vomiting
  • peripheral edema
  • bradycardia
  • palpitations
  • itching
  • arthralgia
  • hypoglycemia
  • rhinitis
  • hypertension
  • blurred vision
  • diplopia
  • vertigo
  • first-degree atrioventricular block
  • tachycardia
  • sinus bradycardia
  • hypotension
  • flushing
  • facial flushing
  • peripheral coldness
  • shortness of breath
  • epistaxis
  • cough
  • nasal congestion
  • rhinitis
  • snoring
  • throat tension
  • nasal dryness
  • vomiting
  • abdominal distension
  • bloating
  • hypersalivation
  • gastroesophageal reflux disease
  • oral sensory loss
  • ascites
  • dysphagia
  • pancreatitis
  • sweating
  • papulovesicular rash
  • urticaria
  • cold sweat
  • muscle cramps
  • back pain
  • limb pain
  • cervical spasms
  • joint swelling
  • myalgia
  • muscle spasms
  • neck pain
  • muscle rigidity
  • rhabdomyolysis
  • urinary disorders
  • urinary incontinence
  • reduced urine output
  • renal failure
  • erectile dysfunction
  • delayed ejaculation
  • sexual dysfunction
  • dysmenorrhea
  • amenorrhea
  • mastalgia
  • breast discharge
  • gynecomastia
  • gait abnormalities
  • falls
  • feeling drunk
  • sensory abnormalities
  • fatigue
  • chest tightness
  • generalized edema
  • pain
  • fever
  • chills
  • weakness
  • thirst
  • increased alanine aminotransferase
  • increased serum creatine phosphokinase
  • increased aspartate aminotransferase
  • increased blood glucose
  • decreased platelet count
  • decreased serum potassium
  • weight loss
  • increased serum creatinine
  • decreased white blood cell count
  • hypersensitivity
  • allergic reactions
  • keratitis
  • congestive heart failure
  • pulmonary edema
  • tongue edema
  • toxic epidermal necrolysis
  • urinary retention
  • gynecomastia
  • lethargy
  • fatigue
  • weakness
  • gait abnormalities
  • decreased libido
  • sleep disorders
  • ataxia
  • speech disorders
  • sensory abnormalities
  • memory impairment
  • attention deficit
  • gastrointestinal disturbances
  • bloody stool
  • increased BUN
  • urinary difficulty
  • abdominal pain
  • upper abdominal pain
  • eyelid edema
  • cataract
  • ear disorders
  • delirium
  • paralysis
  • facial paralysis
  • affective disorders
  • drowsiness
  • state of confusion
  • depression
  • agitation
  • restlessness
  • worsening of seizures
  • shock
  • symptoms resembling anaphylaxis
  • Stevens-Johnson syndrome
  • erythema multiforme

Not everyone experiences these, and they can vary from person to person.

Storage

Store this medication tightly closed to prevent exposure to air or moisture. It is important to maintain storage temperatures between 1 and 30 degrees Celsius to preserve the effectiveness of the medication.

Appearance and packaging

Appearance

White to pale yellow, rectangular, film-coated extended-release tablet

Package unit

30 tablets (6 tablets/PTP x 5)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.